Picture of Adocia SA logo

ADOC Adocia SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Tonghua Dongbao Announces Positive Results In BioChaperone Trials

Oct 23 (Reuters) - Adocia SA  ADOC.PA :
    * ADOCIA’S PARTNER TONGHUA DONGBAO ANNOUNCES POSITIVE
RESULTS OF
THREE CLINICAL TRIALS ON BIOCHAPERONE® COMBO
    * DATA GENERATED ON THREE STUDIES WILL BE SUBMITTED TO CDE
AND
USED TO SUPPORT APPLICATION TO ENTER NEXT CLINICAL DEVELOPMENT
PHASE
    * THREE CLINICAL TRIALS ON BIOCHAPERONE COMBO WERE CONDUCTED
IN
GERMANY ON SUBJECTS WITH TYPE 1 DIABETES, TYPE 2 DIABETES AND ON
HEALTHY VOLUNTEERS WITH CHINESE ORIGIN
    * OVERALL ASSESSMENT SHOWED THAT BC COMBO HAD A GOOD
BENEFIT/RISK
RATIO, SUPPORTING ITS CLINICAL DEVELOPMENT INTO NEXT PHASE

Source text for Eikon:  ID:nBw1SnMV7a 
Further company coverage:  ADOC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Adocia SA

See all news